BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33878635)

  • 21. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
    Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
    Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.
    Lombardi A; Nigri G; Maggi S; Stanzani G; Vitale V; Vecchione A; Nania A; Amanti C
    Surgeon; 2018 Aug; 16(4):232-236. PubMed ID: 29329752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection.
    Kim GR; Choi JS; Han BK; Lee JE; Nam SJ; Ko EY; Ko ES; Lee SK
    Radiology; 2018 Jul; 288(1):55-63. PubMed ID: 29558291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A positive intramammary lymph node does not mandate a complete axillary node dissection.
    Diaz R; Degnim AC; Boughey JC; Nassar A; Jakub JW
    Am J Surg; 2012 Feb; 203(2):151-5. PubMed ID: 21788008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of the functional anatomy of lymphatic drainage to the axilla in early breast cancer: A cohort study of 933 cases.
    Dorogi B; Bukovszky B; Mátrai T; Sávolt Á; Polgár C; Kelemen P; Kovács T; Rényi-Vámos F; Ivády G; Kovács E; Téglás M; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2019 Feb; 45(2):103-109. PubMed ID: 30322669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients.
    Verheuvel NC; Voogd AC; Tjan-Heijnen VC; Roumen RM
    Eur J Surg Oncol; 2016 Aug; 42(8):1162-8. PubMed ID: 27265036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current application of ACOSOG Z0011 trial results: Is further implementation of sentinel lymph node intra-operative histopathological examination mandatory in breast cancer patients - a single-centre analysis.
    Nowikiewicz T; Zegarski W; Pagacz K; Nowacki M; Morawiec-Sztandera A; Glowacka-Mrotek I; Sowa M; Biedka M; Kolacinska A
    Neoplasma; 2018 Mar; 65(3):449-454. PubMed ID: 29788732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolving role of axillary lymph node dissection in the modern era of breast cancer management.
    Barry JM; Weber WP; Sacchini V
    Surg Oncol; 2012 Jun; 21(2):143-5. PubMed ID: 21440434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clinical characteristics between ACOSOG Z0011-eligible cohort and sentinel lymph node-positive breast cancer patients in Hong Kong.
    Man V; Kwong A
    Hong Kong Med J; 2024 Apr; 30(2):139-146. PubMed ID: 38523397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer.
    Gray RJ; Pockaj BA; Conley CR
    Ann Surg Oncol; 2004 Dec; 11(12):1056-60. PubMed ID: 15545503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node?
    Suyoi A; Bains SK; Kothari A; Douek M; Agbaje O; Hamed H; Fentiman I; Pinder S; Purushotham AD
    Eur J Cancer; 2014 Mar; 50(4):690-7. PubMed ID: 24331957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations.
    Aigner J; Smetanay K; Hof H; Sinn HP; Sohn C; Schneeweiss A; Marmé F
    Ann Surg Oncol; 2013 May; 20(5):1538-44. PubMed ID: 23389469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The applicability of the ACOSOG Z0011 Criteria to breast cancer patients in Hong Kong.
    Man V; Lo MS; Kwong A
    Chin Clin Oncol; 2021 Jun; 10(3):27. PubMed ID: 34044545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.
    Olson JA; McCall LM; Beitsch P; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2008 Jul; 26(21):3530-5. PubMed ID: 18640934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?
    Pilewskie M; Jochelson M; Gooch JC; Patil S; Stempel M; Morrow M
    J Am Coll Surg; 2016 Feb; 222(2):138-45. PubMed ID: 26711795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
    Delpech Y; Bricou A; Lousquy R; Hudry D; Jankowski C; Willecocq C; Thoury A; Loustalot C; Coutant C; Barranger E
    Ann Surg Oncol; 2013 Aug; 20(8):2556-61. PubMed ID: 23456432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Axillary management in breast cancer: The French practice versus recommendations in the post-2011 era].
    Clavier A; Cornou C; Capmas P; Bats AS; Bensaid C; Nos C; Lécuru F; Ngô C
    J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):451-8. PubMed ID: 26989008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.